CLASS II Device recall · Reported 12 Jul 2017 · FDA Enforcement Report

Proteus 235 and Proteus ONE proton therapy systems recalled

Ion Beam Applications is recalling Proteus 235 and Proteus ONE proton therapy systems, distributed in 10 states. The recall was initiated on 18 May 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCode/Serial Numbers: PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.110, PAT.111, PAT.112, PAT.113, PAT.114, PAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123 and SAT.126
Quantity recalled18 worldwide and 10, in the U.S.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2672-2017
FDA event ID
77620
Recalling firm
Ion Beam Applications, Louvain La Neuve, N/A
Classification
Class II
Status
Terminated
Recall initiated
18 May 2016
FDA classified
3 Jul 2017
Reported
12 Jul 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

18 May 2016Recall initiated by company
3 Jul 2017Classified by FDA+411 days
12 Jul 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Recall is being initiated to address on-site software installations not being performed consistently with IBA standard operating procedures.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Proteus 235 and Proteus ONE proton therapy systems

Where it was distributed

Products distributed to FL, VA, PA, OK, IL, NJ, WA, TN, LA, TX, South Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden

FloridaIllinoisLouisianaNew JerseyOklahomaPennsylvaniaTennesseeTexasVirginiaWashington

Questions about this recall

Why was it recalled?

Recall is being initiated to address on-site software installations not being performed consistently with IBA standard operating procedures.

Which lots are affected?

Code/Serial Numbers: PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.110, PAT.111, PAT.112, PAT.113, PAT.114, PAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123 and SAT.126

Where was it sold?

Products distributed to FL, VA, PA, OK, IL, NJ, WA, TN, LA, TX, South Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,929